Introduction
The fluid-regulating systems of the body have been of interest to space medicine researchers since results from the earliest flights indicated significant changes in this area (Berry et al. 1966; Dietlein and Harris 1966; Lutwak et al. 1969) . The virtual absence of gravity causes a decrease in posturally induced hydrostatic force in the extremities, which leads to cephalad redistribution of blood. This redistribution is thought to be responsible for most of the spaceflight-induced changes in fluid and electrolyte metabolism. Plasma volume decreases (Johnson 1979 ) and water and electrolyte balances become negative (Leach 1979) in space travelers. In addition to these clear-cut effects, more complex and subtle changes in renal and circulatory dynamics, endocrine function , body biochemistry, and metabolism occur during spaceflight.
Two Phases of the Adaptation Process
Studies in which weightlessness is simulated by decreasing lowerextremity hydrostatic forces (as by bed rest or water immersion) have indicated the presence of at least two phases in the adaptation of the fluid and electrolyte homeostatic systems to microgravity (Leach et al. 1983) . The "acute " phase is believed to occur within a few hours of attaining weightlessness. Since it has been difficult for astronauts to perform experiments early in a fl ight, most of the evidence for existence of this phase has come from simulation studies. Bed-rest studies (Leach et al. 1983; Nixon et al. 1979 ) have shown that central venous pressure (CVP) increases as early as 5 min after bed rest begins (Nixon et al. 1979 ). This is followed by an increase in the size of the left ventricle, but there is no change in cardiac output or arterial pressures (Nixon et aI. 1979) . The increased CVP is thought to be interpreted physiologically as an increase in total blood volume. Glomerular filtration rate (GFR) decreases by about 2 hr and effective renal plasma flow (ERPF) by 4 hr, but both return to pre-bed-rest levels by 8 hr. Plasma aldosterone and antidiuretic l . I R .
eetLOn -epnnts 11. Effects of Weightlessness 139 hormone (ADH) decrease between 1 and 6 hr after the beginning of bed rest (Leac h et al. 1983; Nixon et al. 1979 ). The trans ient acute phase, found in simulation studies and confirmed by recent Spacelab data to be discussed below , leads to a later " adaptive" phase. Evidence for the existence of the adaptive phase has come from blood and urine samples taken in-flight during Gemini , Apollo , Skylab , and Spacelab missions.
Early Spaceflight Findings
Data from limited in-flight samples, along with preflight and postflight measurements of many physiological parameters , provided evidence that mass is lost, water balance becomes negative , electrolytes and certain minerals are depleted , and cardiovascular deconditioning occurs as a result of weightlessness (Berry et al. 1966 ; Hoffler 1977 ; Leach et aJ. 1975) . Fluid , potassium, and nitrogenous compounds were apparently lost from cells as well as from blood (Leach et al. 1975) . Levels of some of the hormones involved in regulating fluid and electrolyte balance were altered; for example , urinary ADH and aldosterone and plasma angiotensin were increased postflight. Plasma volume and red cell mass decreased , and orthostatic tolerance and exercise capacity were reduced (Hoffler and Johnson 1975) .
Skyiab
Experiments for Skylab were planned to document the time course of known physiological changes and to measure additional parameters during long flights . Intake of fluid and nutrients during flight was carefully monitored.
The first in-flight measurements of body mass were performed on Skyl&b (Thornton and Ord 1977) . The crew members lost an average of 2.8 kg, 3.8% of preflight body mass , during flight (Leach and Rambaut 1977) . About half the loss of body mass occurred during the first 2 days of flight, with the rest of the loss being more gradual but continuing throughout the missions. Depletion of water was thought to be responsible for the rapid phase of mass loss and depletion of fat and protein for the slow phase (Leach and Rambaut 1977) .
Increased urinary excretion of water was expected to account for the water deficit. Surprisingly , urinary excretion decreased during the first 10 days of the missions , and free water clearance decreased slightly (Leach and Rambaut 1977) . Water balance studies showed that the main cause of the net body water reduction during the first 2 days of flight was a decrease in fluid intake. To investigate the postulated shift of fluid away from the lower extremities, the leg volume of Skyla b crew members was measured by pleth ysmography . It was estimated that in the first few days of flight , 1.8 I of fluid di sappeared from the legs (Hoffler 1977) , an amount considerably greater than the 600 to 800 ml redi stributed by a change in body position (upright to supine or vice versa) (Sjostrand 1953). The amount of fluid lo st from the legs was almost equal to the total bod y fluid decrement.
The loss of so much body fluid implies that levels of other blood and tissue components are reduced also. Pl as ma osmolality and levels of sodium and chloride were decreased during flight , and the amounts of sodium, potassium , calcium, phosphate , and magnesium were increased in 24-hr urine pool s collected in-flight. Leach and Rambaut (1977) calculated that approximately 100 meq of sod ium were lost from the extracellular space. Electrolytes and other cell constituents may have been translocated from cells to blood. Plas ma levels of potassium , calcium, and phosphate increased during flight.
Plasma angiotensin and urinary a ldosterone and cortisol were increased over their preflight levels during the whole flight but were particularly increased at the beginning of each flight (Leach and Rambaut 1977) . These hormones are released in response to stre ss and to changes in plasma osmolality and electrolytes. Increased angiotensin and aldosterone may have caused at least part of the increased urinary excretion of potassium , but it is unu sual for high level s of aldosterone to be associated with increased sodium excretion. Urinary excretion of antidiuretic hormone (ADH) was decreased during flight , another unexpected finding because the loss of fluid would normally stimul ate ADH secretion , and hyponatremi a persisted in spite of the apparent reduction in ADH.
Renal function was not meas ured directly during the Skylab flight s. Slight increases in creatinine clearance (Leach 1981) , dec reased urinary and pl asma uric acid , and increased plas ma angiotensin indicated that rer.al function may be affected by weightlessness.
Recent Findings from the Space Shuttle
Several experiments involving fluid and electrolyte physiology have now been performed aboard the space shuttle. Venous pressure was meas ured for the first time on Spacelab 1,22 hr after launch (Kirsch et al. 1984) . At th at time venous pressure was lower than it was on the day before launch. Measurement of central and peripheral venous pressures J and J 2 hr after landing indicated that fluid redi stribution after reexposure to gravity was completed between these times. If redistribution caused by microgravity takes about the same amount oftime, it is probably complete before 22 hr.
Studies problems such as space adaptation syndrome or crew members being on different work/rest cycles or being unable to draw blood very soon after reaching orbit or at the same time each day . In one experiment a mission specialist collected his urine as pools representing 5 to 26 hr, and the excretion rates of electrolytes and selected hormones were determined . The earliest change detected in this study was a transient increase in the excretion rate of ADH in the first in-flight sample. This was closely followed by a transient increase in the excretion rate of cortisol. Sodium excretion decreased on the day after the peak in cortisol excretion occurred , but later in the flight it increased. Potassium excretion increased at the sa me time as cortisol excretion on the first day of flight, with smaller peaks on later flight days. Some of these changes may have been caused or affected by the presence of space adaptation sy ndrome. On the sixth and last day of the flight , aldosterone excretion rate tripled, and cortisol and ADH excretion rates increased by lesser amounts. The excretion rates of fluid , potassium, chloride, calcium , and magnesium increased at the same time. The loss of sodi um , which might be expected to result in increased aldosterone secretion, was no greater late in the flight than it had been during the preflight period.
On the Spacelab flight s, blood samples were drawn 22 or more hours after launch. Aldosterone, cortisol, and ADH were measured in blood samples from Spacelab 1 by Dr. K.A . Kirsch (personal communication), and our laboratory has measu red the e and other hormones as well as serum osmolality, sodium, and potassi um in other Spacelab experiments. The fo ur crew members on Spacelab I who participated in experiments were on two different work/rest cycles , but their blood samples were taken at the same clock time, and studies of the circadian rhythms of several urinary variables showed that the circadian rhythm of metabolic functions did not change (Leach, Johnson , & Cintron 1985) . Blood samples were obtained from four mission and payload specialists on Spacelab 2 and two mission specialists on Spacelab 3. The crew members on Spacelab 2 were on two different worklrest cycles, and during flight they collected blood samples during the postsleep activity period. This was 6:30 or 7:00 a. m. Houston time for two crew members and 5:00 or 6:00 p.m. for th e other two. Because of differences in sample collection times, one must be cautious in interpreting the results , but the small number of subjects and time poin ts in anyone experiment makes it desirable to examine the results of these three experiments together.
The combined results for all three Spacelab studies (Leach et al. 1985) showed that hyponatremia developed within 20 hr after the onset of weightlessness and continued throughout the flights , and hypokalemia developed by 40 hr. Serum potassium returned to preflight levels later and then increased. Serum chloride was decreased on most in-flight days on which it was measured, but it immediately returned to preflight levels on landing day.
Antidiuretic hormone, which increased transiently in urine in the shuttle experiment described above and decreased in urine during Skylab flights (Leach and Rambaut 1977) and in plasma during bed rest (Nixon et al. 1979) , was increased in plasma throughout the Spacelab flights . Aldosterone decreased by 40 hr, but after 7 days it had reached preflight levels. Angiotensin I was elevated after 2 days in flight. Cortisol increased early but decreased later in the flight. Adrenocorticotrophic hormone was increased until the seventh day , when levels of cortisol and aldosterone returned to or surpassed baseline.
Current Problems
The changes that occur in human fluid and electrolyte physiology during the acute and adaptiv.e phases of adaptation to spaceflight are summarized in Tables 11 . 1 and 11 .2. A number of questions remain to be an swered. At a time when plasma volume and extracellular fluid volume are contracted and salt and water intake is unrestricted , ADH does not correct the volume deficit and serum sodium decreases. Change in secretion or activity of a natriuretic factor during spaceflight is one possible explanation.
Recent identification of a polypeptide hormone produced in cardiac muscle cells which is natriuretic , is hypotensive , and has an inhibitory effect on renin and aldosterone secretion (Atarashi et al. 1984 ; Pall uk et al . 1985) has renewed interest in the role of a natriuretic factor. The role of this atrial natriuretic factor (ANF) in both long-and short-term variation in extracellular volumes and in the inability of the kidney to bring about an escape from the sodium-retaining state accompanying chronic cardiac dysfunction makes it reasonable to look for a role of ANF in the regulation of sodium during exposure to microgravity. Prostaglandin E is another hormone that may antagonize the action of ADH (Anderson et al. 1976 ). Assays of these hormones will be performed on samples from crew members in the future. 'Cardiovascular intolerance to standing , found to occur immediately after landing in many astronauts, is thought to be related to loss of fluid and electrolytes during weigh tle ss ness . In the space shuttle, reentry acceleration is experienced in the head-to-foot direction because the crew members are sitting upright. The gravitational force in that direction is usuall y a bout 1.2 times the normal 1.0 G (Nicogossian and Parker 1982) . The rapid increase in accleration force s during reentry would be expected to pull bod y fluid s toward the legs. If there has been substantial loss of body fluid , fluid volume in the upper part of the body may decrease enough to cause cardiovascular sy mptoms. Some of these sy mptoms might be allev iated if fluid and electrolyte metabolism were fu ll y re-.. . , adapted to earth ' s gravity before landing. Attempts have bee n made , with so me s uccess, by investigators in the United States a nd Soviet s pace progra ms to prevent or a me liora te orthostatic intolera nce.
One method th a t has been used to counter the o rthostati c intolera nce is fluid a nd electrolyte loading. If fluid a nd electrolytes a re re pl aced , blood vo lume s hou ld begin to increase a nd blood pressure should a pproach preflight leve ls. This should be done before expos ure to the increased acceleration during the deorbit period . It is now standard practice for U .S . as tronaut to consume the equivalent of a liter of ph ysiologi cal salin e so lution in the form of water a nd salt tablets before la nding is initiated . Thi practice has bee n shown to be effective in reducing the seve rity of sy mptom s of cardiovascular deco nditioning (Bungo e t at. 1985) . Similar countermeasures have been used by cosmo naut s on So yuz mi s ion s (G rigori ev 1983) .
Another a pproach to prevention of po tflight orthostatic intolera nce is the use of lower-bod y negative press ure (LBNP) during flight to bring more fluid into th e legs ; thi s has been used with so me ucce s in the Soviet s pace program (Grigoriev 1983) .
There is now co nsiderab le indirect evidence th at re na l function is alte red during weightlessnes (Leach , John so n , & Cintr6 n 1985) , but direct meas urements of renal function have been done o nly in bed-res t s tudi es. Rena l function tes ts will be perfo rmed in conjunction with measurement of hormone , electrol ytes , plas ma volume , a nd other fac tors on Spacelab mi ss ion in the future. Inta ke of food a nd water will be meas ured throughout the mi ss ion , a nd urine will be co llected void by vo id . B lood sa mples will be taken a t interva ls , beginning a t 3 hr after launch , a nd the first renal fun c tion test will start at 3.5 hr. A catheter to measu re central venous press ure will be in serted before la unch a nd removed 12 hr into the flight. Pl as ma volum e a nd extracellul a r fluid w ill be meas ured on the seco nd a nd sixth days of fligh t. These integ ra ted experime nts are expected to provide information importa nt for u ndertanding wh at happens in both phases of the fluid a nd electrol yte respo nse to weightlessness . r I I rection I -Reprints
